TRPV4 and familial dilated cardiomyopathy: TRPV4 inhibitor (RN1734) may improve systolic function in patients with DCM as a result of reduced calcium overloading in DCM hiPSC-CMs and TRPV4-mediated myofibroblasts [80,81].